Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Geriatrics | 12 | 2020 | 94 | 6.300 |
Why?
|
| Periodicals as Topic | 8 | 2017 | 95 | 3.510 |
Why?
|
| Health Services for the Aged | 3 | 2020 | 25 | 2.060 |
Why?
|
| Hypertension | 11 | 2020 | 906 | 1.860 |
Why?
|
| Antihypertensive Agents | 8 | 2020 | 339 | 1.350 |
Why?
|
| Aged | 28 | 2020 | 9487 | 0.990 |
Why?
|
| Academic Medical Centers | 2 | 2020 | 150 | 0.870 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 72 | 0.840 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 77 | 0.840 |
Why?
|
| Humans | 38 | 2020 | 29093 | 0.810 |
Why?
|
| Patient-Centered Care | 2 | 2018 | 68 | 0.790 |
Why?
|
| Publishing | 3 | 2017 | 57 | 0.770 |
Why?
|
| Exercise | 2 | 2020 | 591 | 0.760 |
Why?
|
| Language | 2 | 2017 | 44 | 0.760 |
Why?
|
| Coronavirus | 1 | 2020 | 3 | 0.740 |
Why?
|
| Aged, 80 and over | 12 | 2020 | 3717 | 0.720 |
Why?
|
| American Heart Association | 1 | 2020 | 84 | 0.700 |
Why?
|
| Health Care Costs | 1 | 2020 | 108 | 0.700 |
Why?
|
| Cardiovascular Diseases | 5 | 2017 | 1013 | 0.690 |
Why?
|
| Societies, Medical | 2 | 2016 | 149 | 0.670 |
Why?
|
| United States | 10 | 2020 | 3630 | 0.660 |
Why?
|
| Politics | 1 | 2018 | 20 | 0.640 |
Why?
|
| American Medical Association | 1 | 2017 | 6 | 0.610 |
Why?
|
| Terminology as Topic | 1 | 2017 | 62 | 0.600 |
Why?
|
| Journalism, Medical | 1 | 2016 | 2 | 0.580 |
Why?
|
| Bibliometrics | 1 | 2016 | 9 | 0.580 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 207 | 0.570 |
Why?
|
| Hypotension | 1 | 2015 | 47 | 0.520 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2015 | 20 | 0.510 |
Why?
|
| Quality of Health Care | 1 | 2015 | 134 | 0.480 |
Why?
|
| Electronic Health Records | 1 | 2015 | 118 | 0.470 |
Why?
|
| Health Education | 2 | 2019 | 121 | 0.470 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 162 | 0.460 |
Why?
|
| Dementia | 1 | 2015 | 234 | 0.440 |
Why?
|
| Geriatric Assessment | 6 | 2017 | 355 | 0.420 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2016 | 1379 | 0.400 |
Why?
|
| Mobility Limitation | 3 | 2019 | 187 | 0.380 |
Why?
|
| Female | 21 | 2020 | 18164 | 0.370 |
Why?
|
| Male | 20 | 2020 | 17807 | 0.370 |
Why?
|
| Fatigue | 1 | 2019 | 68 | 0.350 |
Why?
|
| Polypharmacy | 2 | 2020 | 20 | 0.340 |
Why?
|
| Blood Pressure | 5 | 2020 | 804 | 0.330 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2016 | 268 | 0.330 |
Why?
|
| Heart Failure | 4 | 2016 | 568 | 0.290 |
Why?
|
| Hypoglycemic Agents | 2 | 2014 | 176 | 0.220 |
Why?
|
| Fosinopril | 1 | 2002 | 3 | 0.210 |
Why?
|
| Amlodipine | 1 | 2002 | 14 | 0.210 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2002 | 46 | 0.210 |
Why?
|
| Calcium Channel Blockers | 1 | 2002 | 49 | 0.210 |
Why?
|
| Mortality | 1 | 2002 | 109 | 0.200 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 134 | 0.200 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2002 | 126 | 0.190 |
Why?
|
| Body Weight | 1 | 2002 | 290 | 0.190 |
Why?
|
| Patient Compliance | 1 | 2002 | 208 | 0.190 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 142 | 0.190 |
Why?
|
| Assisted Living Facilities | 1 | 2020 | 3 | 0.190 |
Why?
|
| Residential Facilities | 1 | 2020 | 4 | 0.190 |
Why?
|
| Life Style | 2 | 2020 | 364 | 0.190 |
Why?
|
| Nursing Homes | 1 | 2020 | 42 | 0.180 |
Why?
|
| Public Health | 1 | 2020 | 73 | 0.180 |
Why?
|
| Body Mass Index | 1 | 2002 | 865 | 0.170 |
Why?
|
| Medicare | 1 | 2020 | 186 | 0.170 |
Why?
|
| Exercise Therapy | 2 | 2016 | 229 | 0.160 |
Why?
|
| Financing, Organized | 1 | 2018 | 14 | 0.160 |
Why?
|
| Walking | 3 | 2019 | 177 | 0.160 |
Why?
|
| Prospective Studies | 5 | 2019 | 2019 | 0.160 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 68 | 0.160 |
Why?
|
| Feasibility Studies | 1 | 2018 | 263 | 0.160 |
Why?
|
| Death | 1 | 2017 | 41 | 0.150 |
Why?
|
| Disabled Persons | 2 | 2016 | 83 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2018 | 153 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 1 | 2016 | 48 | 0.140 |
Why?
|
| Risk Factors | 7 | 2016 | 3531 | 0.130 |
Why?
|
| Attitude to Computers | 1 | 2015 | 7 | 0.130 |
Why?
|
| Sodium, Dietary | 1 | 2015 | 24 | 0.130 |
Why?
|
| Professional Competence | 1 | 2015 | 16 | 0.130 |
Why?
|
| Interprofessional Relations | 1 | 2015 | 47 | 0.130 |
Why?
|
| Acute Coronary Syndrome | 1 | 2016 | 175 | 0.120 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 247 | 0.120 |
Why?
|
| Body Composition | 1 | 2016 | 365 | 0.120 |
Why?
|
| Ankle Brachial Index | 1 | 2013 | 37 | 0.120 |
Why?
|
| Health Status | 1 | 2016 | 368 | 0.120 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2014 | 79 | 0.120 |
Why?
|
| Independent Living | 1 | 2013 | 78 | 0.110 |
Why?
|
| Middle Aged | 8 | 2016 | 10829 | 0.110 |
Why?
|
| Long QT Syndrome | 1 | 2013 | 39 | 0.110 |
Why?
|
| Hospitalization | 1 | 2016 | 417 | 0.110 |
Why?
|
| Risk Reduction Behavior | 1 | 2013 | 116 | 0.110 |
Why?
|
| Diabetic Angiopathies | 1 | 2013 | 137 | 0.110 |
Why?
|
| Lower Extremity | 1 | 2013 | 93 | 0.110 |
Why?
|
| Electrocardiography | 2 | 2014 | 562 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 412 | 0.110 |
Why?
|
| Adult | 3 | 2020 | 8420 | 0.110 |
Why?
|
| Age Factors | 4 | 2016 | 1108 | 0.100 |
Why?
|
| Atrial Fibrillation | 1 | 2013 | 311 | 0.090 |
Why?
|
| Retrospective Studies | 1 | 2016 | 3111 | 0.080 |
Why?
|
| Activities of Daily Living | 2 | 2016 | 238 | 0.080 |
Why?
|
| Incidence | 3 | 2016 | 1119 | 0.070 |
Why?
|
| Aging | 1 | 2013 | 881 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2016 | 1687 | 0.070 |
Why?
|
| Blood Pressure Determination | 2 | 2016 | 94 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2016 | 3099 | 0.070 |
Why?
|
| Cause of Death | 2 | 2016 | 220 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2002 | 501 | 0.060 |
Why?
|
| Hypoglycemia | 2 | 2014 | 41 | 0.060 |
Why?
|
| Progestins | 1 | 2002 | 18 | 0.060 |
Why?
|
| Weight Lifting | 1 | 2002 | 9 | 0.050 |
Why?
|
| Systole | 1 | 2002 | 87 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2002 | 140 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2002 | 94 | 0.050 |
Why?
|
| Emotions | 1 | 2002 | 48 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2002 | 68 | 0.050 |
Why?
|
| Heart Diseases | 1 | 2002 | 97 | 0.050 |
Why?
|
| Carotid Artery Diseases | 1 | 2002 | 109 | 0.050 |
Why?
|
| Weight Gain | 1 | 2002 | 108 | 0.050 |
Why?
|
| Depressive Disorder | 1 | 2002 | 74 | 0.050 |
Why?
|
| Estrogens | 1 | 2002 | 162 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2014 | 466 | 0.050 |
Why?
|
| Osteoarthritis, Knee | 1 | 2002 | 80 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2002 | 447 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2002 | 125 | 0.050 |
Why?
|
| Single-Blind Method | 2 | 2016 | 165 | 0.050 |
Why?
|
| Postmenopause | 1 | 2002 | 397 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2002 | 464 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2016 | 1305 | 0.040 |
Why?
|
| Weight Loss | 1 | 2002 | 413 | 0.040 |
Why?
|
| Stroke | 1 | 2002 | 545 | 0.040 |
Why?
|
| Pennsylvania | 1 | 2016 | 77 | 0.040 |
Why?
|
| Tennessee | 1 | 2016 | 97 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 273 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 2108 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2016 | 67 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2016 | 65 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 274 | 0.030 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2015 | 20 | 0.030 |
Why?
|
| Appetite | 1 | 2015 | 19 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2015 | 163 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 374 | 0.030 |
Why?
|
| Continental Population Groups | 1 | 2015 | 221 | 0.030 |
Why?
|
| Exercise Test | 1 | 2013 | 194 | 0.030 |
Why?
|
| Coronary Disease | 1 | 2014 | 200 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 2013 | 110 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 709 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 720 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 787 | 0.030 |
Why?
|
| Prevalence | 1 | 2013 | 896 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 366 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 1362 | 0.020 |
Why?
|
| Tunica Media | 1 | 2002 | 29 | 0.010 |
Why?
|
| Tunica Intima | 1 | 2002 | 59 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2002 | 92 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2002 | 182 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2002 | 364 | 0.010 |
Why?
|
| Disease Progression | 1 | 2002 | 572 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2002 | 251 | 0.010 |
Why?
|
| Pain | 1 | 2002 | 282 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 863 | 0.010 |
Why?
|